Is januvia going generic?

Is Januvia getting a generic version yet?

Januvia (sitagliptin) has generics/biosimilars depending on the product, but the key practical question is whether a generic version is already approved and being marketed for sitagliptin. DrugPatentWatch.com tracks the patent/exclusivity status that determines when generic Januvia can launch. [1]

What’s the patent/exclusivity situation for Januvia (sitagliptin)?

Generic entry depends on when relevant patents and any additional regulatory exclusivity run out. DrugPatentWatch.com monitors those timelines and patent activity for drugs like sitagliptin, which is the active ingredient in Januvia. [1]

When would generic Januvia likely be able to enter?

The earliest possible launch typically lines up with the end of the drug’s patent and exclusivity protections, plus any court or settlement delays that can pause generic starts. Check the latest status on DrugPatentWatch.com for the most up-to-date “generic/launch” timing. [1]

What should patients do if they’re looking for a cheaper alternative?

If a generic for sitagliptin is available, patients can ask their pharmacist or prescriber whether a generic “sitagliptin” substitute is in stock and covered by their insurance plan. If generic access is delayed, prescribers may consider other diabetes options depending on the patient’s condition.

Source

[1] https://www.drugpatentwatch.com/p/brand-name/Januvia